DiaMedica Therapeutics(DMAC) - 2024 Q3 - Quarterly Results

Exhibit 99.1 DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results Conference Call and Webcast Thursday November 14 at 8:00 AM Eastern Time / 7:00 AM Central Time ● Implemented Updates to AIS Program Intended to Enhance Probability of Trial Success and Expedite Study Completion, with Potential for a Reduced Study Size ● Preeclampsia Phase 2 Trial Received Regulatory Approval and First Patient Dosed ● Cash Runway Into Q3 2026 Minneapolis, Minnesota – November 13 ...